icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
November 13 - 16 - 2020
Back grey_arrow_rt.gif
 
 
 
Hepatitis D (Delta) at AASLD 2021
 
 
 

HDV

Who is at risk for HDV infection?
 
The following populations are at increased risk for becoming infected with HDV:
 
• People chronically infected with HBV
• Infants born to mothers infected with HDV
• Sex partners of persons infected with HDV
• Men who have sex with men
• People who inject drugs
• Household contacts of people with HDV infection
• Health care and public safety workers at risk for occupational exposure to blood or blood-contaminated body fluids
• Hemodialysis patients
 
https://www.cdc.gov/hepatitis/hdv/hdvfaq.htm
 
AASLD: Prevalence and Characteristics of Hepatitis Delta in the United States: an Analysis of All-Payer Claims Databases - (11/17/21)
 
AASLD: Strong intrahepatic decline of hepatitis D virus RNA and antigen after 48 weeks of treatment with Bulevirtide in chronic HBV/HDV co-infected patients: Interim results from a multicenter, open-label, randomized phase 3 clinical trial (MYR301) - (11/16/21)
 
AASLD: EFFICACY OF LONG-TERM TREATMENT OF CHRONIC HEPATITIS D PATIENTS WITH BULEVIRTIDE - RESULTS OF A "REAL WORLD" STUDY (11/23/21)
 
AASLD: HDV Hospital Admissions Rare-But Sometimes Severe-in United States - (11/20/21)
 
AASLD: Hepatitis D-Associated Hospitalizations in the United States: 2010-2018 - (11/19/21)
 
AASLD: MOLECULAR AND CLINICAL EPIDEMIOLOGY OF HEPATITIS D VIRUS INFECTION IN CANADA - (11/19/21)
 
AASLD: Low adherence to guidelines recommendations for hepatitis D testing in HBsAg-positive patients leads to high undiagnosis rates - (11/19/21)
 
AASLD: Over 90% of Clinicians Ignore EACS Hep D Screening Advice - (11/19/21)
 
AASLD: Safety and Efficacy of 2 mg Bulevirtide in Patients with Chronic HBV/HDV Co-Infection: First Real-World Results - (11/17/21)
 
AASLD: Higher Baseline Comorbidities and Liver Disease Severity Among Patients With Hepatitis Delta Infection vs Hepatitis B Monoinfection: a National US Claims Database Analysis - (11/15/21)